JP2024507528A5 - - Google Patents
Info
- Publication number
- JP2024507528A5 JP2024507528A5 JP2023550249A JP2023550249A JP2024507528A5 JP 2024507528 A5 JP2024507528 A5 JP 2024507528A5 JP 2023550249 A JP2023550249 A JP 2023550249A JP 2023550249 A JP2023550249 A JP 2023550249A JP 2024507528 A5 JP2024507528 A5 JP 2024507528A5
- Authority
- JP
- Japan
- Prior art keywords
- microsphere
- polymer
- lurasidone
- formulation according
- biodegradable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163152943P | 2021-02-24 | 2021-02-24 | |
| US63/152,943 | 2021-02-24 | ||
| US202263267403P | 2022-02-01 | 2022-02-01 | |
| US63/267,403 | 2022-02-01 | ||
| PCT/US2022/070807 WO2022183196A1 (en) | 2021-02-24 | 2022-02-24 | Microsphere formulations comprising lurasidone and methods for making and using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507528A JP2024507528A (ja) | 2024-02-20 |
| JP2024507528A5 true JP2024507528A5 (https=) | 2025-02-25 |
Family
ID=82900191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550249A Pending JP2024507528A (ja) | 2021-02-24 | 2022-02-24 | ルラシドンを含むミクロスフェア製剤ならびにその製造方法および使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11992559B2 (https=) |
| EP (1) | EP4297753A4 (https=) |
| JP (1) | JP2024507528A (https=) |
| KR (1) | KR20230157365A (https=) |
| AU (1) | AU2022226584A1 (https=) |
| CA (1) | CA3210098A1 (https=) |
| IL (1) | IL304650A (https=) |
| MX (1) | MX2023009754A (https=) |
| WO (1) | WO2022183196A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119424341A (zh) * | 2023-08-02 | 2025-02-14 | 珠海市华海康医药科技有限责任公司 | 一种注射用药物缓释微球及其制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
| US5288502A (en) | 1991-10-16 | 1994-02-22 | The University Of Texas System | Preparation and uses of multi-phase microspheres |
| DE69431404T2 (de) | 1993-10-22 | 2003-04-30 | Genentech Inc., San Francisco | Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe |
| CN1074923C (zh) | 1993-11-19 | 2001-11-21 | 詹森药业有限公司 | 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类 |
| ES2427092T3 (es) | 2003-04-10 | 2013-10-28 | Evonik Corporation | Un método para la producción de micropartículas a base de emulsión |
| CN1852687B (zh) | 2003-07-15 | 2014-01-22 | 赢创有限公司 | 控释组合物的制备方法 |
| ES2600554T3 (es) | 2003-07-18 | 2017-02-09 | Oakwood Laboratories L.L.C. | Prevención de la reducción del peso molecular del polímero, de la formación de impurezas y de la gelificación en composiciones poliméricas |
| JP5165240B2 (ja) | 2003-07-23 | 2013-03-21 | ピーアール ファーマシューティカルズ， インコーポレイテッド | 徐放組成物 |
| US8283352B2 (en) | 2005-06-13 | 2012-10-09 | Dainippon Sumitomo Pharma Co., Ltd. | Solubilization preparation |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| ES2420479T3 (es) | 2006-08-31 | 2013-08-23 | Sk Chemicals, Co., Ltd. | Procedimiento para la producción de microesferas cargadas con fármacos y microesferas cargadas con fármacos producidas mediante el mismo |
| WO2009085952A1 (en) | 2007-12-20 | 2009-07-09 | Brookwood Pharmaceuticals, Inc. | Process for preparing microparticles having a low residual solvent volume |
| SG176735A1 (en) | 2009-06-10 | 2012-01-30 | Sunovion Pharmaceuticals Inc | Histamine h3 inverse agonists and antagonists and methods of use thereof |
| EP2521711B1 (en) | 2010-01-07 | 2017-08-16 | Alkermes Pharma Ireland Limited | Quaternary ammonium salt prodrugs |
| US10335366B2 (en) * | 2010-05-31 | 2019-07-02 | Laboratorios Farmacéuticos Rovi, S.A. | Risperidone or paliperidone implant formulation |
| EP2629775A4 (en) | 2010-10-18 | 2014-06-11 | Dainippon Sumitomo Pharma Co | INJECTABLE FORMULATION WITH DELAYED RELEASE |
| SG190009A1 (en) | 2010-11-24 | 2013-06-28 | Univ Nanyang Tech | Method for encapsulating particles |
| US20120202823A1 (en) | 2010-12-23 | 2012-08-09 | Alkermes, Inc. | Multi-API Loading Prodrugs |
| ES2950418T3 (es) | 2012-03-19 | 2023-10-09 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas que comprenden alcohol bencílico |
| WO2014076712A2 (en) | 2012-11-14 | 2014-05-22 | Hetero Research Foundation | Lurasidone hydrochloride solid dispersion |
| WO2014144309A1 (en) * | 2013-03-15 | 2014-09-18 | Oakwood Laboratories | Sustained release microspheres and method of producing the same |
| US9636308B2 (en) | 2013-03-15 | 2017-05-02 | Oakwood Laboratories LLC | High drug load buprenorphine microspheres and method of producing same |
| US9393211B2 (en) | 2013-03-15 | 2016-07-19 | Oakwood Laboratories LLC | High drug load buprenorphine microspheres and method of producing same |
| US9943484B2 (en) * | 2013-06-20 | 2018-04-17 | Pharmathen S.A. | Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile |
| KR102373288B1 (ko) * | 2013-12-03 | 2022-03-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| US20150157628A1 (en) | 2013-12-11 | 2015-06-11 | Saravanan Kannusamy | Pharmaceutical compositions of Lurasidone and Process for preparation thereof |
| WO2016111913A1 (en) | 2015-01-05 | 2016-07-14 | Boston Scientific Scimed, Inc. | Biodegradable drug eluting microsphere for the treatment of solid tumors |
| WO2017059106A1 (en) | 2015-09-30 | 2017-04-06 | Indivior Uk Limited | Psychiatric treatment for patients with gene polymorphisms |
| WO2017119928A1 (en) | 2016-01-08 | 2017-07-13 | Abon Pharmaceuticals, Llc | Long acting injectable formulations |
| WO2018015915A1 (en) | 2016-07-22 | 2018-01-25 | Cadila Healthcare Limited | A parenteral controlled release composition of an atypical antipsychotic agent |
-
2022
- 2022-02-24 CA CA3210098A patent/CA3210098A1/en active Pending
- 2022-02-24 MX MX2023009754A patent/MX2023009754A/es unknown
- 2022-02-24 AU AU2022226584A patent/AU2022226584A1/en active Pending
- 2022-02-24 JP JP2023550249A patent/JP2024507528A/ja active Pending
- 2022-02-24 KR KR1020237032096A patent/KR20230157365A/ko active Pending
- 2022-02-24 EP EP22760617.5A patent/EP4297753A4/en active Pending
- 2022-02-24 US US17/679,385 patent/US11992559B2/en active Active
- 2022-02-24 WO PCT/US2022/070807 patent/WO2022183196A1/en not_active Ceased
-
2023
- 2023-07-23 IL IL304650A patent/IL304650A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mahar et al. | Application of PLGA as a biodegradable and biocompatible polymer for pulmonary delivery of drugs | |
| Domb et al. | Biodegradable polymers in clinical use and clinical development | |
| US10463619B2 (en) | Injectable delivery of microparticles and compositions therefor | |
| JP2017141477A5 (https=) | ||
| Patel et al. | Biodegradable polymers: emerging excipients for the pharmaceutical and medical device industries | |
| JP2005508893A5 (https=) | ||
| JP2005510521A5 (https=) | ||
| JP2005525403A5 (https=) | ||
| CN106421800A (zh) | 丝素蛋白改性凹坑结构乳酸基聚合物载药微球及制备方法 | |
| Villalba-Rodriguez et al. | Bio-inspired biomaterials and their drug delivery perspectives-A review | |
| CN109414401A (zh) | 用于胃肠外给药的生物可降解聚合物微球组合物 | |
| JP2024507528A5 (https=) | ||
| Hosseini et al. | A review on synthesis, characterization and applications of polycaprolactone as a novel drug delivery system and tissue engineering | |
| CN121013711A (zh) | 用于治疗关节病诸如骨关节炎的包含秋水仙碱的关节内注射剂型 | |
| Tsung et al. | Biodegradable polymers in drug delivery systems | |
| CN101522169B (zh) | 在延长的一段时间里释放活性成分的皮下植入剂 | |
| Koocheki et al. | Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride | |
| Al-Domi et al. | Development of an insulin nano-delivery system through buccal administration | |
| Sahu et al. | Nanofibers in drug delivery | |
| CN1437933A (zh) | 可生物降解性高分子材料包裹利福平微球的制备方法 | |
| US20120164207A1 (en) | Degradable networks for sustained release and controlled release depot drug delivery applications | |
| Fulzele et al. | Novel Biopolymers as Implant Matrix for the Deliveryof Ciprofloxacin: Biocompatibility, Degradation, and In Vitro Antibiotic Release | |
| CN101810586B (zh) | 左旋多巴甲酯缓释微球组合物及其制备方法 | |
| US9216142B2 (en) | High-glass transition temperature absorbable microspheres | |
| Garg et al. | Enhancing periodontal defences with nanofiber treatment: recent advances and future prospects |